🔴 Immunitybio is trading 4.38% down today while biotech sector gains

Immunitybio is trading 4.38% down at $8.88, with no new company announcement or confirmed fundamental catalyst clearly explaining the September 23 decline.

• The decline reversed part of the September 22, 2026 rally, when shares closed at $9.29, up 9.94%.
• Recent attention has centered on retail speculation around Nant’s proposed blockchain-enabled trading platform, not a confirmed ImmunityBio corporate event.
• Immunitybio is underperforming the broader biotech sector, which is up 2.07% during regular trading.